Back to Search
SEBASTIAN LIGHVANI, MD
MD
Specialist
NPI: 1407879885IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
230079(NY)
CMS Specialties
PrimaryALLERGY/IMMUNOLOGY
Education
OTHER
Class of 1995
Research & Publications (7)
Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
PMID 17251480·Invest Ophthalmol Vis Sci·2007
7-preclinical
Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation.
PMID 17202374·J Immunol·2007
7-preclinical
IFN-gamma: regulation of nitric oxide in the P. aeruginosa-infected cornea.
PMID 16507487·Ocul Immunol Inflamm·2006
4-observational
Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
PMID 16384971·Invest Ophthalmol Vis Sci·2006
7-preclinical
Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
PMID 15832292·Eur J Immunol·2005
7-preclinical
Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
PMID 11818386·Invest Ophthalmol Vis Sci·2002
7-preclinical
Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.
PMID 11721755·Am J Gastroenterol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 186 E 76TH ST, 2ND FLOOR
NEW YORK, NY 10021 - Phone
- (212) 517-3300
Quick Facts
- NPI
- 1407879885
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 7
Are you this provider?
Claim Your Profile